Literature DB >> 18508849

Percutaneous revascularization of grafts versus native coronary arteries in postcoronary artery bypass graft patients.

Julio Garcia-Tejada1, Maite Velazquez, Felipe Hernandez, Agustín Albarran, Sergio Rodriguez, Ivan Gomez, Javier Andreu, Juan Tascon.   

Abstract

In patients with previous coronary artery bypass graft surgery, it is unknown whether better results may be obtained with percutaneous interventions of grafts versus native arteries. The clinical outcomes in 84 patients undergoing percutaneous interventions of either grafts (n = 31) or native arteries (n = 53) were compared. Procedural success rate was 95.3% (96.8% in the graft group vs 94.4% in the native group, P = .3). Mean follow-up was 19 +/- 7 months. The incidence of major adverse events was 14.2% (12.9% vs 15.1% in the graft and native groups, respectively; P = .8), mortality rate was 3.5% (6.4% vs 1.8% in the graft and native groups, respectively; P = .3), and target-lesion revascularization was performed in 4.7% (6.4% vs 3.7% in the graft and native groups, respectively, P = .6). In conclusion, both graft or native percutaneous interventions were similar for immediate and midterm clinical outcomes. The relatively low risk need for target-lesion revascularization obtained with both strategies is encouraging.

Entities:  

Mesh:

Year:  2008        PMID: 18508849     DOI: 10.1177/0003319708317335

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  2 in total

1.  Successful retrograde recanalization of an acute iatrogenic venous graft occlusion through the previously stented coronary anastomosis in a patient with non-ST elevation myocardial infarction.

Authors:  Sergey V Vlasenko; Maksim V Agarkov; Anton A Khilchuk; Sergey G Scherbak; Andrey M Sarana; Vitaliy V Popov; Dana D Abdulkarim
Journal:  Radiol Case Rep       Date:  2018-06-14

Review 2.  Risks and complications of coronary angiography: a comprehensive review.

Authors:  Morteza Tavakol; Salman Ashraf; Sorin J Brener
Journal:  Glob J Health Sci       Date:  2012-01-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.